The immunology of Epstein–Barr virus infection
- 29 April 2001
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions Of The Royal Society B-Biological Sciences
- Vol. 356 (1408) , 475-488
- https://doi.org/10.1098/rstb.2000.0784
Abstract
Epstein–Barr virus is a classic example of a persistent human virus that has caught the imagination of immunologists, virologists and oncologists because of the juxtaposition of a number of important properties. First, the ability of the virus to immortalize B lymphocytesin vitrohas provided an antigen presenting cell in which all the latent antigens of the virus are displayed and are available for systematic study. Second, the virus presents an ideal system for studying the immune parameters that maintain latency and the consequences of disturbing this cell–virus relationship. Third, this wealth of immunological background has provided a platform for elucidating the role of the immune system in protection from viral–associated malignancies of B cell and epithelial cell origin. Finally, attention is now being directed towards the development of vaccine formulations which might have broad application in the control of human malignancies.Keywords
This publication has 132 references indexed in Scilit:
- A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.Journal of Clinical Investigation, 1998
- Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivityEuropean Journal of Immunology, 1997
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- Human leukocyte antigen phenotype imposes complex constraints on the antigen‐specific cytotoxic T lymphocyte repertoireEuropean Journal of Immunology, 1997
- The Molecular Basis of AllorecognitionAnnual Review of Immunology, 1993
- Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virusEuropean Journal of Immunology, 1992
- Limiting dilution analysis of human T cells: a useful clinical toolImmunology Today, 1990
- The molecular basis of alloreactivityImmunology Today, 1990
- Differential expression of hla antigen of HLA anigens on human B-cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells?International Journal of Cancer, 1988
- Virus-specific MHC-restricted T lymphocytes may initiate allograft rejectionImmunology Today, 1985